Evaluation of pleural disease with 18-fluorodeoxyglucose positron emission tomography imaging
Study objectives To study the ability of positron emission tomography (PET) using 18-
fluorodeoxyglucose (FDG) to distinguish between benign and malignant disease in …
fluorodeoxyglucose (FDG) to distinguish between benign and malignant disease in …
Evaluation of pleural disease with 18-fluorodeoxyglucose positron emission tomography imaging
B Duysinx, D Nguyen, R Louis, D Cataldo… - …, 2004 - pubmed.ncbi.nlm.nih.gov
Study objectives To study the ability of positron emission tomography (PET) using 18-
fluorodeoxyglucose (FDG) to distinguish between benign and malignant disease in …
fluorodeoxyglucose (FDG) to distinguish between benign and malignant disease in …
Evaluation of Pleural Disease With 18-Fluorodeoxyglucose Positron Emission Tomography Imaging
B Duysinx, D Nguyen, L Renaud, D Cataldo - Chest, 2004 - search.proquest.com
STUDY OBJECTIVES: To study the ability of positron emission tomography (PET) using 18-
fluorodeoxyglucose (FDG) to distinguish between benign and malignant disease in …
fluorodeoxyglucose (FDG) to distinguish between benign and malignant disease in …
[PDF][PDF] Evaluation of Pleural Disease With 18-Fluorodeoxyglucose Positron Emission Tomography Imaging
B Duysinx, D Nguyen, R Louis, D Cataldo, T Belhocine… - CHEST, 2004 - researchgate.net
Study objectives: To study the ability of positron emission tomography (PET) using 18-
fluorode-oxyglucose (FDG) to distinguish between benign and malignant disease in …
fluorode-oxyglucose (FDG) to distinguish between benign and malignant disease in …
Evaluation of pleural disease with 18-fluorodeoxyglucose positron emission tomography imaging.
B Duysinx, D Nguyen, R Louis, D Cataldo, T Belhocine… - Chest, 2004 - europepmc.org
Study objectives To study the ability of positron emission tomography (PET) using 18-
fluorodeoxyglucose (FDG) to distinguish between benign and malignant disease in …
fluorodeoxyglucose (FDG) to distinguish between benign and malignant disease in …
Evaluation of Pleural Disease With 18-Fluorodeoxyglucose Positron Emission Tomography Imaging
B Duysinx, D Nguyen, R Louis, D Cataldo… - …, 2004 - journal.chestnet.org
Study objectives To study the ability of positron emission tomography (PET) using 18-
fluorodeoxyglucose (FDG) to distinguish between benign and malignant disease in …
fluorodeoxyglucose (FDG) to distinguish between benign and malignant disease in …
[引用][C] Evaluation of pleural disease with 18-fluorodeoxyglucose positron emission tomography imaging
B DUYSINX, D NGUYEN, R LOUIS, D CATALDO… - Chest, 2004 - pascal-francis.inist.fr
Evaluation of pleural disease with 18-fluorodeoxyglucose positron emission tomography
imaging CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …
imaging CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …
[PDF][PDF] Evaluation of Pleural Disease With 18-Fluorodeoxyglucose Positron Emission Tomography Imaging
B Duysinx, D Nguyen, R Louis, D Cataldo, T Belhocine… - CHEST, 2004 - academia.edu
Study objectives: To study the ability of positron emission tomography (PET) using 18-
fluorode-oxyglucose (FDG) to distinguish between benign and malignant disease in …
fluorode-oxyglucose (FDG) to distinguish between benign and malignant disease in …
Evaluation of pleural disease with 18-fluorodeoxyglucose positron emission tomography imaging
B Duysinx, D Nguyen, R Louis, D Cataldo, T Belhocine… - CHEST, 2004 - orbi.uliege.be
STUDY OBJECTIVES: To study the ability of positron emission tomography (PET) using 18-
fluorodeoxyglucose (FDG) to distinguish between benign and malignant disease in …
fluorodeoxyglucose (FDG) to distinguish between benign and malignant disease in …
Evaluation of pleural disease with 18-fluorodeoxyglucose positron emission tomography imaging
B Duysinx, D Nguyen, R Louis, D Cataldo, T Belhocine… - Chest, 2004 - go.gale.com
Study objectives: To study the ability of positron emission tomography (PET) using 18-
fluorodeoxyglucose (FDG) to distinguish between benign and malignant disease in …
fluorodeoxyglucose (FDG) to distinguish between benign and malignant disease in …